Idorsia Ltd (OTCMKTS:IDRSF – Get Free Report) shares shot up 1.5% during trading on Monday . The company traded as high as $4.09 and last traded at $4.09. 2,000 shares traded hands during mid-day trading, a decline of 87% from the average session volume of 15,675 shares. The stock had previously closed at $4.03.
Idorsia Price Performance
The firm has a 50-day moving average of $4.54 and a two-hundred day moving average of $4.57.
Idorsia Company Profile
Idorsia Ltd is a Swiss biopharmaceutical company founded in 2017 as a spin-off from Actelion following its acquisition by Johnson & Johnson. Headquartered in Allschwil, Switzerland, Idorsia focuses on the discovery, development and commercialization of innovative small-molecule therapeutics. The company’s R&D efforts span multiple therapeutic areas, including neuroscience, cardiovascular and immunology, with the goal of addressing unmet medical needs through novel mechanisms of action.
Among Idorsia’s lead products is daridorexant, a dual orexin receptor antagonist developed for the treatment of insomnia.
Recommended Stories
Receive News & Ratings for Idorsia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Idorsia and related companies with MarketBeat.com's FREE daily email newsletter.
